SCHEMBL747153

SCHEMBL747153

O=C1CCSCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22658159 0.84
SCHEMBL10101158 0.78 CRBN (0.53)
SCHEMBL4240098 0.76
SCHEMBL18396750 0.72
Thiazolidine SCHEMBL8794184 0.72 CRBN (0.52)
SCHEMBL57039 0.71
SCHEMBL27471834 0.69
SCHEMBL27475685 0.69
SCHEMBL1593092 0.69
2-Pyrrolidone SCHEMBL27529551 0.67 OR51E2 (0.62)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1706147-A2 COMBINATION THERAPY WITH 5-HT sb 1A /sb AND 5-HT sb 1B /sb RECEPTOR ANTAGONISTS Recordati Ireland Limited (IE) 2006-10-04 EP claimed
WO-2005070460-A2 COMBINATION THERAPY WITH 5-HT1A AND 5-HT1B RECEPTOR ANTAGONISTS RECORDATI IRELAND LIMITED (IE) 2005-08-04 WO claimed
WO-2023190015-A1 1-ARYL TETRAHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE OR SALT THEREOF, PESTICIDE CONTAINING SAID COMPOUND, AND METHOD FOR USING SAME 日本農薬株式会社 2023-10-05 WO disclosed
WO-2014169845-A2 4,5-DIHYDRO-PYRAZOLO [3, 4-C] PYRID-2-ONES, PREPARATION METHOD AND APPLICATION THEREOF 四川海思科制药有限公司 (CN) 2014-10-23 WO disclosed
US-20130338367-A1 PYRAZOLE DERIVATIVES AND PESTICIDES NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2013-12-19 US disclosed
EP-2674423-A1 PYRAZOLE DERIVATIVE AND PEST CONTROL AGENT Nissan Chemical Industries, Ltd. (JP) 2013-12-18 EP disclosed
US-20120088759-A1 THIAZOLIDIN-4-ONE AND [1,3]-THIAZINAN-4-ONE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD. (CH) 2012-04-12 US disclosed
US-20120088759-A1 THIAZOLIDIN-4-ONE AND [1,3]-THIAZINAN-4-ONE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD. (CH) 2012-04-12 US disclosed
CN-102413828-A Thiazolidin-4-one and [1,3] -thiazinan-4-one compounds as orexin receptor antagonists ACTELION PHARMACEUTICALS LTD 2012-04-11 CN disclosed
CN-102413828-A Thiazolidin-4-one and [1,3] -thiazinan-4-one compounds as orexin receptor antagonists ACTELION PHARMACEUTICALS LTD 2012-04-11 CN disclosed
EP-2429523-A1 THIAZOLIDIN-4-ONE AND [1,3]-THIAZINAN-4-ONE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2012-03-21 EP disclosed
US-6627627-B2 Useful as psychotherapeutic agents PFIZER INC. 2003-09-30 US disclosed
CN-1031570-C Pyrazolopyridine compound and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO (JP) 1996-04-17 CN disclosed
US-5155114-A Treating or preventing renal toxicity, nephrosis, nephritis FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1992-10-13 US disclosed
US-5098899-A Method for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites TRUSTEES OF BOSTON UNIVERSITY (US) 1992-03-24 US disclosed
US-4985444-A Pyrazolopyridine compound and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-01-15 US disclosed
EP-0379979-A1 Pyrazolopyridine compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-08-01 EP disclosed
EP-0236931-A2 Aromatic omega-alkylimino-tetrahydro-6H-1,3-Thiazin-6-one derivatives MERRELL DOW PHARMACEUTICALS INC. (US) 1987-09-16 EP disclosed
US-4301151-A OLIGOPEPTIDES CONTAINING A 1,3-THIAZIN-4-ONE RING OR A N-HETERO-4-ONE RINGS MERCK & CO., INC. (US) 1981-11-17 US disclosed
US-4254107-A Long-lasting agonists of enkephalin MERCK & CO., INC. (US) 1981-03-03 US disclosed